July 1 (HealthDay News) -- The OneTouch Ping glucose management meter, which communicates without wires to a pump that delivers insulin to people with diabetes, has been approved by the U.S. Food and Drug Administration, maker Animas Corp. said Tuesday.

The system allows users to receive an insulin dose -- based on the meter reading -- without the person touching the pump, said Animas, a subsidiary of Johnson & Johnson.

Insulin pumps are small devices commonly clipped to a belt or clothing, delivering insulin through a catheter that's inserted under the skin.

The device is waterproof up to 12 feet for 24 hours, Animas said in a statement.